Model: FibroScan® Expert 630.
Manufacturer: Echosens.
Original: France.
Stiffness measurement: fibrosis assessment of Fibroscan®.
Pioneer in the field of liver elastography.
FibroScan® produces biomarkers that can assess and monitor patients over time.
FibroScan® uses uniform algorithms that minimize inter-operator variability and eliminate inter-system variability.
Stiffness & CAP™ measurements.
Liver Fibrosis: LSM by VCTE™ is unique, patented, and validated for liver fibrosis assessment.
Portal hypertension: SSM by VCTE™ is unique, patented, and validated for portal hypertension assessment. SSM by VCTE™ can be used for risk stratification of patients with advanced CLD.
Liver Steatosis: CAP™ is unique, patented, and validated for liver steatosis assessment.
Smart Exam Technology
Improve reliability in the diagnosis and monitoring of steatosis with continuous CAP™. Extend usage among severely obese patients with the deeper assessment of liver fibrosis and steatosis. Dedicate more time to patient care with tasks automation.
Spleen Stiffness Measurement SSM™.
Spleen stiffness and liver stiffness were more accurate than other non-invasive parameters in identifying patients with esophageal varicose veins and differents degrees of portal hypertension.
Embedded ultrasound guidance.
Time-saving to locate spleen and liver on obese and complex patients.
Non-invasive – Fast measurement.
New spleen stiffness measurement and embedded ultrasound guidance system for risk stratification of patients with advanced chronic liver disease.
Stiffness & CAP™ results are the median of 10 valid measurements.
Embedded ultrasound guidance: applied before spleen examination for easier targeting of the spleen.
FibroScan® Expert 630 - Measurement screen.
FibroScan® Expert 630 - Patient data.
FibroScan® Expert 630 - New spleen stiffness measurement.
FibroScan® Expert 630 is the perfect liver assessment solution.
Echosens - France.
Echosens is the world’s #1 provider of non-invasive medical devices dedicated to assessment of chronic liver disease. Echosens significantly changed the practice of liver diagnosis with FibroScan®. The unique device using patented and validated VCTE™ for liver stiffness assessment. CAP™ for steatosis quantification. FibroScan® is recognized worldwide as the reference for non-invasive liver diagnosis with more than 2,500 medical publications, 40 guidelines recommendations and more than 6,5OO devices installed worldwide. We are working hand in hand with physicians, medical academics, research pharmaceutical companies for patient identification and monitoring in NAFLD/ NASH.
FibroScan® Demonstration Exam.
Discover FibroScan®, the state of the art technology that will improve your liver diagnosis. This unique, accurate and efficient device brings you extra clinical confidence to support your patient management.
At Echosens, we envison a future where medical professionals. Their patients have the best tools and information to assess and manage liver health. Find out more about Echosens and FibroScan in this video.
Related products
Non-invasive – Fast measurement.
New spleen stiffness measurement and embedded ultrasound guidance system for risk stratification of patients with advanced chronic liver disease.
Stiffness & CAP™ results are the median of 10 valid measurements.
Embedded ultrasound guidance: applied before spleen examination for easier targeting of the spleen.
FibroScan® Expert 630 - Measurement screen.
FibroScan® Expert 630 - Patient data.
FibroScan® Expert 630 - New spleen stiffness measurement.
